Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M379Revenue $M12.4Net Margin (%)-89.7Z-Score23.7
Enterprise Value $M305EPS $-0.3Operating Margin %-99.8F-Score5
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-86.8Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %0Quick Ratio11.4Cash flow > EarningsN
Price/Sales29.65-y EBITDA Growth Rate %0Current Ratio11.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-10.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-12.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M50.3ROI % (ttm)-71.8Gross Margin Increase y-yY

Gurus Latest Trades with CGEN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CGEN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about CGEN :

    Quarterly/Annual Reports about CGEN:

      News about CGEN:

      Articles On GuruFocus.com
      creiter note on CGEN Jan 03 2010 
      Compugen Reports Second Quarter 2009 Results Jul 28 2009 
      Compugen Ltd. Reports Fourth Quarter and Year-End 2008 Financial Results Feb 11 2009 
      Compugen Ltd. to Review Fourth Quarter and Year-End 2008 Financial Results on Wednesday, February 11 Feb 04 2009 

      More From Other Websites
      Compugen Expands and Strengthens Business Development Team Mar 19 2015
      Compugen Announces Planned Relocation of Headquarters to Larger Facilities Mar 19 2015
      Zacks Rank #1 Additions for Wednesday - Tale of the Tape Mar 11 2015
      Compugen to Present at Two Oncology Conferences in March Mar 02 2015
      Compugen to Present at Two Oncology Conferences in March Mar 02 2015
      Moving Average Crossover Alert: Compugen (CGEN) - Tale of the Tape Feb 27 2015
      Compugen Expands and Strengthens Business Development Team Feb 23 2015
      [video]'Mad Money' Lightning Round: J&J Must Get Its Game Back Feb 21 2015
      Compugen Fourth Quarter and Yearend 2014 Conference Call Scheduled for Tuesday, February 10, 2015 at... Feb 18 2015
      Compugen Ltd. Reports Fourth Quarter and Calendar 2014 Results Feb 18 2015
      Compugen reports 4Q loss Feb 10 2015
      Compugen reports 4Q loss Feb 10 2015
      Compugen Ltd. Reports Fourth Quarter and Calendar 2014 Results Feb 10 2015
      Compugen Presents New Results Supporting CGEN-15049 as Potential Cancer Immunotherapy Target Feb 09 2015
      Compugen Presents New Results Supporting CGEN-15049 as Potential Cancer Immunotherapy Target Feb 09 2015
      Compugen Fourth Quarter and Year-End 2014 Conference Call Scheduled for Tuesday, February 10, 2015... Feb 03 2015
      Compugen to Present Cancer Immunotherapy Targets at Two Tumor Immunology Conferences This Month Feb 02 2015
      Compugen to Present Cancer Immunotherapy Targets at Two Tumor Immunology Conferences This Month Feb 02 2015
      Compugen Discloses Initial Experimental Results for Predicted Antibody Drug Conjugate Targets Jan 05 2015
      Compugen Discloses Initial Experimental Results for Predicted Antibody Drug Conjugate Targets Jan 05 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK